Psi Pharma Support Poland Sp. z o.o. operates as the Polish entity of PSI, a global contract research organization delivering clinical research services to pharmaceutical, biotechnology and healthcare sponsors. The companys core business segment is clinical trial delivery, including feasibility and site selection support, study start-up, project management, monitoring, medical oversight, regulatory and ethics documentation coordination, pharmacovigilance-related interfaces, and quality management aligned with international clinical research standards. Complementary service lines include data management, statistical programming and analysis, clinical supplies coordination, and technology-enabled trial planning and performance management through the groups proprietary platforms used to model enrollment scenarios and control milestones. PSI focuses on pivotal and late-phase development as well as complex programs across multiple therapeutic areas, supporting sponsors requiring operational reliability, predictable delivery timelines and data quality. Geographic reach is international through the PSI global operating model, with the Polish organization supporting domestic execution and cross-border studies from its Warsaw office while contributing to multinational programs spanning Europe and other regions. Key assets include specialized clinical operations teams, therapeutic-area expertise supported by centralized medical monitoring resources, standardized quality systems, and integration with PSI technology platforms for feasibility and delivery control. Strategic positioning is based on a full-service, sponsor-oriented CRO model with emphasis on on-time delivery, operational discipline, and scalable resourcing for global clinical development programs.
Headquarters
Ul. Hrubieszowska 6B
Warsaw; Mazowieckie;
Postal Code: 01-209
Contact Details: Purchase the Psi Pharma Support Poland Sp. z o.o. report to view the information.
Website: http://www.psi-cro.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service